These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1992043)

  • 1. Iodine-125-MIBG therapy for neuroblastoma.
    Hoefnagel CA; Smets L; Voûte PA; de Kraku J
    J Nucl Med; 1991 Feb; 32(2):361-2. PubMed ID: 1992043
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
    Sisson JC; Shapiro B; Hutchinson RJ; Zasadny KR; Mallette S; Mudgett EE; Wieland DM
    J Nucl Biol Med (1991); 1991; 35(4):255-9. PubMed ID: 1823830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric models and S factors for radiation doses to the bladder wall in children receiving therapeutic iodine-131-MIBG.
    Bolster AA; Hilditch TE; Wheldon TE
    J Nucl Med; 1995 Aug; 36(8):1530-1. PubMed ID: 7629603
    [No Abstract]   [Full Text] [Related]  

  • 4. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
    Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
    J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
    O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
    Prog Clin Biol Res; 1991; 366():455-61. PubMed ID: 2068160
    [No Abstract]   [Full Text] [Related]  

  • 6. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
    Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Session on the treatment of neuroblastoma with radioiodinated metaiodobenzylguanidine. Chairmen's report.
    Mastrangelo R; Voûte PA
    J Nucl Biol Med (1991); 1991; 35(4):260-2. PubMed ID: 1823831
    [No Abstract]   [Full Text] [Related]  

  • 8. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
    Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Session on the biology and treatment of neuroblastoma as related to metaiodobenzylguanidine. Chairmen's report.
    Sisson JC; De Bernardi B
    J Nucl Biol Med (1991); 1991; 35(4):199-201. PubMed ID: 1823818
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.
    Klingebiel T; Bruchelt G; Kaleva N; Wollmann H; Handgretinger R; Treuner J; Gupta D; Niethammer D
    Prog Clin Biol Res; 1991; 366():509-12. PubMed ID: 2068167
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.
    Hutchinson RJ; Sisson JC; Miser JS; Zasadny KR; Normolle DP; Shulkin BL; Francis IR; Wieland DM; Shapiro B
    J Nucl Biol Med (1991); 1991; 35(4):237-40. PubMed ID: 1823826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy.
    Troncone L; Rufini V; Riccardi R; Lasorella A; Mastrangelo R
    J Nucl Biol Med (1991); 1991; 35(4):232-6. PubMed ID: 1823825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with palliative [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Gasparini M; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):241-3. PubMed ID: 1726677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy.
    Rutgers M; Gubbels AA; Hoefnagel CA; Voûte PA; Smets LA
    Prog Clin Biol Res; 1991; 366():471-8. PubMed ID: 2068162
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Société Française d'Oncologie Pédiatrique" and Nuclear Medicine Co-investigators.
    Lumbroso J; Hartmann O; Schlumberger M
    J Nucl Biol Med (1991); 1991; 35(4):220-3. PubMed ID: 1823822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.
    Smets LA; Rutgers M
    J Nucl Biol Med (1991); 1991; 35(4):191-4. PubMed ID: 1823816
    [No Abstract]   [Full Text] [Related]  

  • 17. [Iodobenzylguanide-131 therapy as first choice in non-metastasized neuroblastoma].
    De Kraker J; Hoefnagel CA; Caron HN; Vos A; Bras J; Greve JC
    Ned Tijdschr Geneeskd; 1996 Oct; 140(40):1997-2000. PubMed ID: 8965930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabelled mIBG in the treatment of neuroblastoma.
    Gaze MN; Wheldon TE
    Eur J Cancer; 1996 Jan; 32A(1):93-6. PubMed ID: 8695251
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
    Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ
    Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.